We bring together biology and technology to enable food producers to improve their sustainability and profitability.
Investment Proposition
High growth markets
Focus on established, fast growing markets of genetics, health and specialist nutrition serving the increasingly important aquaculture sector.
Unique model
Benchmark has a differentiated model bringing together genetics, health and specialist nutrition, which combined can contribute significantly to improve the sustainability and profitability of aquaculture producers.
Barriers to competition
Market leadership, strong patent portfolio, long established breeding programmes and accredited manufacturing capability.
Scalable
Global distribution network and production capacity to support growth.
Potential to deliver high shareholder returns
Our platform is capable of delivering double-digit growth and a 25% Adjusted EBITDA margin in the next three to five years.
Strategy
- Grow in established markets from existing capacity and through partnerships
- Commercial delivery of pipeline products
- Focused investment in markets that leverage Group platform
- Position Benchmark in areas of future growth
Share Price (GBX)
Regulatory News
Click the video to watch
Benchmark team discuss £43m raise and commercial development of CleanTreat
Financial Calendar
| Date | Title |
|---|---|
| December 2019 | Publication of year end results |
| February 2020 | Q1 update |
| March 2020 | Annual General Meeting |
| May 2020 | Publication of Interim results |
| August 2020 | Q3 update |
| November 2020 | Q4 update |
| December 2020 | Publication of year end results |
H1 2019 Financial Highlights
+3%
Revenue
£78.3m
Revenue
+25%
increase in Adjusted EBITDA
£7.5m
Adjusted EBITDA
9.6%
Adjusted EBITDA Margin
£8.5m
R&D Investment
| £m | H1 2019 | H1 2018 | Change % | Constant Currency Change5 % |
|---|---|---|---|---|
| Adjusted | ||||
| Revenue | 78.3 | 75.7 | 3% | 2% |
| Adjusted EBITDA 1 | 7.5 | 6.0 | 25% | 23% |
| Adjusted Operating Profit2 | 2.7 | 2.9 | (7%) | 10% |
| Adjusted Profit Before Tax 3 | 0.7 | 3.6 | (80%) | (86%) |
| Statutory | ||||
| Revenue | 78.3 | 75.7 | 3% | 2% |
| Loss before tax | (8.3) | (5.6) | (48%) | (50%) |
| (Loss)/Profit for the period | (9.1) | 3.6 | (353%) | (355%) |
| Basic loss/earnings per share (pence) | (1.71) | 0.67 | (355%) | |
| Net Debt 4 | (65.5) | (41.3) | (59%) |
2 Adjusted Operating Profit is operating loss before exceptional items including acquisition related items and amortisation of intangible assets excluding development costs as shown in note 16 to the condensed consolidated financial statements
3 Adjusted profit before tax is earnings before tax, amortisation and impairment of acquired intangibles, exceptional items and acquisition related expenditure as shown in note 16 to the condensed consolidated financial statements
4 Net debt is cash and cash equivalents less loans and borrowings as shown in note 16 to the condensed consolidated financial statements
5 Constant Currency change reflects the percentage change after retranslating 2019 figures using the same foreign exchange rates experienced in 2018.